ClinicalTrials.gov
public full text
Public Domain
Diurnal Variation of Plasminogen Activator Inhibitor-1
To determine if nighttime administration of an aldosterone antagonist would effectively lower peak plasma Plasminogen Activator Inhibitor-1 (PAI-1) levels more effectively than morning administration.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder#840578
- Reflexology Versus Progressive Muscle Relaxation for Fatigue in Hemodialysis Patients#912296
- RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough#832061
- The interactive effect of long nighttime sleep and daytime napping on QTc prolongation in hypertensive adults.#1007
- Effect of Intra-Dialytic Muscle Energy Technique on Restless Leg Syndrome in Hemodialysis Patients#841938
Record · ID 844716
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive